|
Characteristics
|
Patient group
|
P value
|
|---|
| |
1
|
2
|
3
|
Total
| |
|---|
|
Subjects
(
n
)
|
29
|
21
|
15
|
65
| |
|
Male
/
Female
(
n
)
|
20/8a
|
11/9b
|
9/6
|
40/23c
|
0.5
|
|
Age
(years)
|
19 (9-29)d
|
8 (7-26)
|
16 (9-21)
|
15 (8-24)e
|
0.2
|
|
Hb level
(
g
/
dL)
|
9.6 (7.1-12.4)
|
10.3 (9.1-11.2)
|
9.9 (7.5-11.5)
|
10.0 (8.4-11.4)
|
0.8
|
|
WBC count
/mm
3
|
5650 (4925-6900)f
|
6800 (5900-8000)g
|
5400 (4250-7150)h
|
6050 (4950-7400)i
|
0.2
|
|
DAT titer
|
25600 (6400-102400)
|
NA
|
12800 (6400-102400)
|
19200 (6400-102400)
|
0.9†
|
|
P.f
.
parasitaemia
(parasites/μL)
|
NA
|
825 (355-2325)j
|
53 (38-585)k
|
370 (51-1113)l
|
0.005‡
|
- When not otherwise indicated, data shown represent median and (interquartile range).
- Hb = hemoglobin; WBC = white blood cell; DAT = direct agglutination test; P.f. = Plasmodium falciparum; NA = not applicable.
- Groups 1 to 3 are: 1 = visceral leishmaniasis patients, 2 = malaria patients, 3 = visceral leishmaniasis-malaria co-infected patients.
- The Kruskall-Wallis test was used to calculate the P values, except for the variable sex for which the Chi-Square test was used, and for the variables DAT titer and P.f. parasitaemia, for which the Mann-Whitney test was used.
- †P value refers to differences between groups 1 and 3 only.
- ‡P value refers to differences between groups 2 and 3 only.
- Sex data based on a 28 patients b 20 patients c 63 patients. Age data based on d 27 patients and e 63 patients. WBC count data based on f 18 patients, g 11 patients, h 13 patients and i 42 patients. P. falciparum parasitaemia data based on j 12 patients, k 10 patients and l 22 patients. Two co-infected patients received artemether i.m. three weeks prior to diagnosis and their data on P. falciparum parasitaemia were excluded to reduce possible bias.
